Avantor, Inc. $AVTR Shares Bought by Cetera Investment Advisers

Cetera Investment Advisers grew its stake in shares of Avantor, Inc. (NYSE:AVTR) by 33.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,746 shares of the company’s stock after acquiring an additional 7,227 shares during the quarter. Cetera Investment Advisers’ holdings in Avantor were worth $466,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of AVTR. Wealthquest Corp acquired a new position in shares of Avantor during the 1st quarter valued at about $34,000. GAMMA Investing LLC increased its position in Avantor by 121.6% during the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock worth $61,000 after purchasing an additional 2,056 shares in the last quarter. Fifth Third Bancorp increased its position in Avantor by 52.0% during the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock worth $64,000 after purchasing an additional 1,359 shares in the last quarter. Signaturefd LLC increased its position in Avantor by 19.8% during the 1st quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock worth $89,000 after purchasing an additional 904 shares in the last quarter. Finally, Archer Investment Corp acquired a new stake in Avantor during the 1st quarter worth approximately $112,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Robert W. Baird dropped their target price on shares of Avantor from $18.00 to $15.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Evercore ISI reduced their target price on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Morgan Stanley reduced their price objective on Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Monday, August 4th. Royal Bank Of Canada reduced their price objective on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Finally, TD Cowen cut Avantor from a “buy” rating to a “hold” rating and set a $15.50 target price on the stock. in a research note on Monday, April 28th. Eight analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $15.50.

Avantor Trading Down 0.5%

NYSE:AVTR opened at $12.91 on Monday. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. Avantor, Inc. has a 1-year low of $10.82 and a 1-year high of $27.83. The firm has a market capitalization of $8.80 billion, a price-to-earnings ratio of 13.04, a price-to-earnings-growth ratio of 1.46 and a beta of 0.96. The stock has a fifty day simple moving average of $13.19 and a 200 day simple moving average of $14.70.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business earned $0.25 EPS. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. Sell-side analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the transaction, the chief accounting officer owned 55,068 shares of the company’s stock, valued at $627,224.52. The trade was a 5.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Gregory L. Summe bought 30,000 shares of the stock in a transaction on Friday, May 23rd. The shares were acquired at an average cost of $12.50 per share, for a total transaction of $375,000.00. Following the purchase, the director owned 100,000 shares in the company, valued at approximately $1,250,000. This represents a 42.86% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.20% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.